Header Logo

Connection

JULIE NANGIA to Receptors, Estrogen

Back to Details
This is a "connection" page, showing publications JULIE NANGIA has written about Receptors, Estrogen.
JULIE NANGIA
Connection Strength
0.032
Receptors, Estrogen
  1. TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer. Clin Cancer Res. 2020 02 15; 26(4):821-827.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.